Fundraising Fox
/People
Sign in

Brett Chevalier

Investor

Venture Partner at Anterra Capital

Cambridge, Massachusetts

Writes $1M – $20M checks · typically $5M

Find your path to Brett

592 people in our graph can introduce you to Brett.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Devin Leake to introduce you to Brett

You →Devin · together at Orogen Therapeutics (2023–2026) →Brett

Ask Jamie Chen to introduce you to Brett

You →Jamie · 2 people · together at Animol →Brett

Ask Sam Okafor to introduce you to Brett

You →Sam · together at Whitehead Institute →Brett

Sign up to find every way you can get introduced to Brett

  • Your email: the people you already email who know Brett
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Brett
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Brett Chevalier serves as Chief Scientific Officer at Anterra Capital, where he focuses on company creation in the biosciences. His work spans human therapeutics and discovery platforms, with expanding interests in biotech applications for animal health, agriculture, and environmental solutions.

Experience

  1. Anterra CapitalChief Scientific Officercurrent2018 — presentBoston, Massachusetts
  2. Orogen TherapeuticsScientific Co-Founder, Interim VP Ops and CSO, Board Observercurrent2023 — presentGreater Boston
  3. BiomEditBoard Observercurrent2022 — presentIndiana, United States
  4. Animol Discovery, Inc.Scientific Co-Founder, SAB, Board Observercurrent2020 — presentGreater Boston
  5. CAMP4 TherapeuticsHead Of Operations2015 — 2018Cambridge, MA
  6. CorviumAdvisor2010 — 2016Boston, MA
  7. CorviumFounder and Chief Scientific Officer2010 — 2012Greater Boston Area
  8. Flagship VenturesNew Venture Associate2008 — 2009Cambridge, MA
  9. Whitehead InstituteResearch Scientist2006 — 2008Cambridge, MA
  10. Agilent TechnologiesSenior Scientist (Systems Biology)2005 — 2006Cambridge, MA

Skills & more

Team LeadershipStart-ups2Entrepreneurship2Technical LeadershipStrategic LeadershipBusiness StrategyVenture Capital3FundraisingPatentsPatent ApplicationsTechnology Transfer3Patent Portfolio Analysis
+9 moreProtein EngineeringProtein CrystallizationProtein ExpressionMicrobiologyEmbryonic Stem CellsCancer ResearchCancer Stem CellsProteomicsGenomics

From Brett's professional profile.

Colleagues at Anterra Capital

Adam Anders
Managing Partner and Co-Founder at Anterra Capital
Andrew Calabrese
Investor at Anterra Capital
Anneke Stelte
Investor at Anterra Capital
Axel Wehr
Venture Partner at Anterra Capital
Bela Jankovich
Advisor at Anterra Capital
Brett Wong
Principal at Anterra Capital
Dudley Hawes
Partner at Anterra Capital
Juergen Horn
Advisor at Anterra Capital

Network5

Adam Anders
Managing Partner and Co-Founder at Anterra Capital
Andrew Calabrese
Investor at Anterra Capital
Anneke Stelte
Investor at Anterra Capital
Axel Wehr
Venture Partner at Anterra Capital
Bela Jankovich
Advisor at Anterra Capital

Investors connected to Brett in public investor directories — a warm-intro map.

Frequently asked questions

Who is Brett Chevalier?
Brett Chevalier serves as Chief Scientific Officer at Anterra Capital, where he focuses on company creation in the biosciences. His work spans human therapeutics and discovery platforms, with expanding interests in biotech applications for animal health, agriculture, and environmental solutions.
Where does Brett Chevalier work?
Brett Chevalier is Venture Partner at Anterra Capital.
What check size does Brett Chevalier write?
Brett Chevalier typically writes checks of $1M – $20M.
Where did Brett Chevalier go to school?
Brett Chevalier studied at Massachusetts Institute of Technology (Merck LSRF Fellow, Stem and iPS cells); University of Washington (PhD, Protein Design and Engineering); Carleton College (BA, Biology).

Founder mafias

Same school

Shared employers